同: IVIG, IGFV, Gamimune, Sandoglobulin
関: Intravenous immunoglobulin

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 免疫グロブリンの静脈内投与：副作用 intravenous immune globulin adverse effects
2. 免疫グロブリンの使用における一般原則 general principles in the use of immune globulin
3. 血液疾患における免疫グロブリンの静脈内投与 intravenous immune globulin in hematologic disorders
4. 敗血症性ショック：小児における蘇生後の継続的マネージメント septic shock ongoing management after resuscitation in children
5. 難治性の尋常性天疱瘡および落葉状天疱瘡のマネージメント management of refractory pemphigus vulgaris and pemphigus foliaceus

English Journal

Follow-up nerve conduction studies in CIDP after treatment with IGIV-C: Comparison of patients with and without subsequent relapse.

Chin RL1, Deng C2, Bril V3, Hartung HP4, Merkies IS5, Donofrio PD6, Van Doorn PA7, Dalakas MC8, Latov N1.
Muscle & nerve.Muscle Nerve.2015 Oct;52(4):498-502. doi: 10.1002/mus.24624. Epub 2015 Jul 24.
INTRODUCTION: Electrodiagnostic studies (EDX) are not performed routinely before treatment suspension in CIDP, and no data exist regarding their value in predicting clinical relapse.METHODS: Serial EDX (baseline and after IGIV-C therapy) were analyzed from subjects in the ICE clinical trial who resp
PMID 25728021

Complementary use of passive surveillance and Mini-Sentinel to better characterize hemolysis after immune globulin.

Winiecki S1, Baer B1, Chege W1, Jankosky C1, Mintz P2, Baker M3,4, Woodworth T3, Nguyen M1.
Transfusion.Transfusion.2015 Jul;55 Suppl 2:S28-35. doi: 10.1111/trf.13116.
BACKGROUND: Hemolysis after intravenous immune globulins (IGIVs) is a known complication, but expanding indications and recent manufacturing changes warrant ongoing postmarketing surveillance. Characterization of post-IGIV hemolysis to date has been limited to small case series.STUDY DESIGN AND METH
PMID 26174895

Modulatory role of intravenous gammaglobulin (IgIV) on the in vitro antibody response to a pneumococcal polysaccharide antigen.

Leiva LE1, Monjure H, Sorensen RU.
Journal of clinical immunology.J Clin Immunol.2015 Feb;35(2):206-12. doi: 10.1007/s10875-014-0120-6. Epub 2014 Dec 12.
INTRODUCTION: Clinical observations in patients with specific antibody deficiency treated for periods of time with IgG infusion have suggested that IgG may have a positive immunoregulatory effect on the production of specific antibodies against pneumococcal polysaccharides. We developed an in vitro
PMID 25504423

Japanese Journal

Prevention of respiratory syncytial virus infections : Indications for the use of palivizumab and update on the use of RSV-IGIV

American Academy of Pediatrics Committee on Infectious Diseases and Committee of Fetus and Newborn
Pediatrics 102, 1211-1216, 1998
NAID 30012912446

Optimal dosage and differences in therapeutic efficacy of IGIV in Kawasaki disease

ONOUCHI ZENSHIRO,YANAGISAWA MASAYOSHI,HIRAYAMA TSUNEO,KIYOSAWA NOBUYUKI,MATSUDA HIROSHI,NAKASHIMA MITSUYOSHI
Acta paediatrica Japonica 37(1), 40-46, 1995-02-01
NAID 10010502140

Related Pictures

reference index « Gamimune N 10% IGIV IGIV-X defeats Dre in GMPGL 4-3 DN finals Cangene discloses development of IGIV IGIV Therapy Results of IGIV for Alzheimer’s Study La terapia con IGIV produce un estado de Drugs reference index « Privigen IGIV » com españa la tercera generación de igiv